中文名：Cerdulatinib 鹽酸鹽
英文名：Cerdulatinib hydrochloride
英文別名：1369761-01-2|Cerdulatinib hydrochloride|Cerdulatinib HCl|Cerdulatinib HCl salt|RVT-502 hydrochloride|Cerdulatinib (hydrochloride)|L1KRM66Y4X|4-(cyclopropylamino)-2-[4-(4-ethylsulfonylpiperazin-1-yl)anilino]pyrimidine-5-carboxamide;hydrochloride|PRT2070|Ce
純度：98%
貨號：C413796
包裝：10mg、200mg、50mg
Cas號：1369761-01-2
存儲溫度：-20°C儲存
產品介紹：
產品介紹：
Cerdulatinib hydrochloride 是一種選擇性可逆，具有口服活性、 ATP 競爭性的Syk和JAK的雙重抑制劑，它可用于研究自身免疫性疾病和B細胞惡性腫瘤。
激酶實驗：Purified Kinase Assays: Potency against purified SYK is determined by fluorescence resonance energy transfer. A broader panel of 270 purified kinases is surveyed in which PRT062070 is tested at a fixed concentration of 300 nM. [33P]-labeled substrate is measured after incubation of purified kinase with peptide substrate and [33P]ATP at the Km concentration for the kinase.
細胞實驗：Cell lines (Ramos RA-1, Daudi, Toledo, SU-DHL4 and SU-DHL6) are cultured in RPMI media supplemented with 10% fetal bovine serum. Cells are treated with the indicated concentrations of PRT062070, the SYK-selective inhibitor PRT060318, the pan-JAK inhibitor 1, a 1:1 combination of PRT060318 and JAK inhibitor 1, or vehicle control (0.5% dimethylsulfoxide) for 72 hours. Cell viability assays are performed using CellTiter Glo in 384-well plates. Cells are seeded at a density of 5000 cells per well. (Only for Reference)
查看阿拉丁官網此產品相關對應頁面：https://www.aladdin-e.com/zh_cn/C413796.html
關鍵字： 1369761-01-2;Cerdulatinib hydrochloride;Cerdulatinib HCl;Cerdulatinib HCl salt
上海阿拉丁生化科技股份有限公司是A股上市公司（（股票代碼：688179），專注于科研試劑的研發(fā)、生產和銷售，已陸續(xù)建立多個工廠和研發(fā)中心。作為領軍企業(yè)，阿拉丁始終堅持質量第一，連續(xù)13年被評為“最受歡迎試劑品牌”。
阿拉丁目前常備庫存試劑產品品種超過7萬種，SKU總數超過46萬，產品線涵蓋了化學試劑、生化試劑、藥靶配體、蛋白質和抗體等多個領域，是國內少數化學試劑到生物試劑全面發(fā)展的國產試劑品牌，產品同步發(fā)布在我們國內外電商平臺。